108 related articles for article (PubMed ID: 8912405)
1. Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test.
Ballard TM; Hunter AJ; Bennett GW
Psychopharmacology (Berl); 1996 Oct; 127(3):265-75. PubMed ID: 8912405
[TBL] [Abstract][Full Text] [Related]
2. Effects of a thyrotropin releasing hormone analogue on locomotor and other motor activity in the rat.
Clarke KA; Parker AJ
Neuropeptides; 1985 Apr; 6(2):101-12. PubMed ID: 3923383
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the motor behaviours produced by the intrathecal administration of thyrotrophin-releasing hormone and thyrotrophin-releasing hormone analogues in the conscious rat.
Johnson JV; Fone KC; Havler ME; Tulloch IF; Bennett GW; Marsden CA
Neuroscience; 1989; 29(2):463-70. PubMed ID: 2498761
[TBL] [Abstract][Full Text] [Related]
4. Behavioral profile of the TRH analogue RX77368 in developing rats.
Jackson HC
Peptides; 1990; 11(5):897-901. PubMed ID: 2126622
[TBL] [Abstract][Full Text] [Related]
5. Motoneurone excitability after administration of a thyrotrophin releasing hormone analogue.
Clarke KA; Stirk G
Br J Pharmacol; 1983 Nov; 80(3):561-5. PubMed ID: 6416344
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin releasing hormone (TRH) and a degradation stabilized analogue (RX77368) stimulate phosphoinositide turnover in cultured astrocytes in a regionally specific manner.
McDermott AM; Dickinson SL; Wilkin GP
Neurochem Int; 1992 Apr; 20(3):307-13. PubMed ID: 1338971
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the locomotor effects induced by centrally injected TRH and TRH analogues.
Sharp T; Bennett GW; Marsden CA; Tulloch IF
Regul Pept; 1984 Nov; 9(4):305-15. PubMed ID: 6441196
[TBL] [Abstract][Full Text] [Related]
8. Effects of an analogue of thyrotrophin-releasing hormone, RX77368, on infarct size and cerebral blood flow in focal cerebral ischaemia in the rat.
O'Shaughnessy CT; Rothwell NJ; Shrewsbury-Gee J
Can J Physiol Pharmacol; 1989 Oct; 67(10):1345-50. PubMed ID: 2514979
[TBL] [Abstract][Full Text] [Related]
9. Further studies on the effects of a thyrotropin releasing hormone analogue on locomotor activity in the rat.
Clarke KA; Parker AJ
Neuropeptides; 1986; 8(2):99-109. PubMed ID: 3093913
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin-releasing hormone analogue and serotonin interact within the dorsal vagal complex to augment gastric acid secretion.
McTigue DM; Rogers RC; Stephens RL
Neurosci Lett; 1992 Sep; 144(1-2):61-4. PubMed ID: 1436715
[TBL] [Abstract][Full Text] [Related]
11. Effects of risperidone on locomotor activity and spatial memory in rats with hippocampal damage.
Bardgett ME; Baum KT; O'Connell SM; Lee NM; Hon JC
Neuropharmacology; 2006 Dec; 51(7-8):1156-62. PubMed ID: 16934300
[TBL] [Abstract][Full Text] [Related]
12. Motoneurone excitability during antidromically evoked inhibition after administration of a thyrotrophin releasing hormone (TRH) analogue.
Clarke KA; Parker AJ; Stirk GC
Neuropeptides; 1984 Sep; 4(5):403-11. PubMed ID: 6436727
[TBL] [Abstract][Full Text] [Related]
13. Development of a radioimmunoassay for RX77368 (pGlu-His-3,3-dimethyl proline amide)--a stable analogue of thyrotrophin releasing hormone (TRH).
Lynn AG; Bennett GW
J Pharm Biomed Anal; 1991; 9(1):9-18. PubMed ID: 1904280
[TBL] [Abstract][Full Text] [Related]
14. Behavioural effects of scopolamine and the TRH analogue RX77368 on radial arm maze performance in the rat.
Watson CD; Hewitt MJ; Fone KC; Dickinson SL; Bennett GW
J Psychopharmacol; 1994 Jan; 8(2):88-93. PubMed ID: 22298534
[TBL] [Abstract][Full Text] [Related]
15. Role of brainstem thyrotropin-releasing hormone-triggered sympathetic overactivation in cardiovascular mortality in type 2 diabetic Goto-Kakizaki rats.
Yang H; Nyby MD; Ao Y; Chen A; Adelson DW; Smutko V; Wijesuriya J; Go VL; Tuck ML
Hypertens Res; 2012 Feb; 35(2):157-65. PubMed ID: 21900943
[TBL] [Abstract][Full Text] [Related]
16. Controlled acute trial of a thyrotrophin releasing hormone analogue (RX77368) in motor neuron disease.
Guiloff RJ; Eckland DJ; Demaine C; Hoare RC; MacRae KD; Lightman SL
J Neurol Neurosurg Psychiatry; 1987 Oct; 50(10):1359-70. PubMed ID: 3119776
[TBL] [Abstract][Full Text] [Related]
17. Brainstem thyrotropin-releasing hormone regulates food intake through vagal-dependent cholinergic stimulation of ghrelin secretion.
Ao Y; Go VL; Toy N; Li T; Wang Y; Song MK; Reeve JR; Liu Y; Yang H
Endocrinology; 2006 Dec; 147(12):6004-10. PubMed ID: 16959836
[TBL] [Abstract][Full Text] [Related]
18. Induction of wet-dog shaking in rats by analogues and metabolites of thyrotrophin-releasing hormone (TRH).
Webster VA; Griffiths EC; Slater P
Regul Pept; 1982 Dec; 5(1):43-51. PubMed ID: 6820171
[TBL] [Abstract][Full Text] [Related]
19. The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers.
Coupland NJ; Bailey JE; Glue P; Nutt DJ
Br J Clin Pharmacol; 1995 Sep; 40(3):223-9. PubMed ID: 8527283
[TBL] [Abstract][Full Text] [Related]
20. TRH analogue affects information transfer through the ventrobasal thalamus.
Clarke KA
Neuropeptides; 1986 Jan; 7(1):31-9. PubMed ID: 3081829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
